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In the third period of epidemiological 
transition in the late twentieth century, 
coronary heart disease (CHD) and its risk 
factors, in many countries, including Iran, 
have become a major health problem.1, 2 
Non-communicable diseases NCDs are 
estimated to contribute to almost 60% of 
mortalities worldwide and 43% of the global 
burden of disease in 1999. With current 
trends, by 2020 these diseases are predicted 
to account for 73% of deaths and 60% of the 
disease burden.3 NCDs are already of major 
importance in developed countries and are 
rapidly turning into a major public health 
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ABSTRACT 
Background and aims: Coronary heart diseases (CHDs) contribute to mortality, 
morbidity, disability, productivity and quality of life. This study was aimed to determine 
the prevalence of major risk factors for CHD in the provinces of Iran. 
Methods: This study reported pre-existing data and was of secondary, descriptive type. 
Prevalence of non-communicable disease (NCD) risk factors was defined for the 
provinces of Iran. A reliable report of NCD risk factors, the national surveillance 
program conducted in Iran, such as type II diabetes, hypertension and mean body mass 
index (BMI), smoking, hookah smoking, high cholesterol and obesity was used. 
Results: The highest and lowest prevalence of hypertension was obtained in Bushehr 
(20.85%) and Yazd (12.86%) provinces, respectively. The highest mean BMI was 
reported from Mazandaran province (26) and the lowest from Sistan and Baluchestan 
province (22.50). Qom province had the highest prevalence of diabetes (27.65%). The 
highest prevalence of high cholesterol was obtained in Lorestan province (50.87 %) and 
the lowest in the Khouzestan province (22.71%). East Azarbaijan province had the 
highest prevalence of smoking (14.8%) and Kurdistan province the lowest (0.16%). 
Hookah smoking was most prevalent in Hormozgan province (7.62%). The highest 
prevalence of physical activities was reported from Sistan and Baluchestan province 
(47.84%) and the lowest from Kohgiluyeh and Boyer-Ahmad (22.2%). 
Conclusion: Prevalence of CHD risk factors is the main priority for the Iranian health 
system. There is a need for intervention programs in the provinces which are at greater 
risk as well as for modification of people’s lifestyle. 
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threat in the developing countries. Over a 
period of 30 years, the burden of NCDs for 
developing and newly industrialized 
countries is expected to rise by more than 
60% by 2020, less than a rise of less than 
10% in developed countries.4,5 The 
underlying cause of this epidemic is the 
increase in lifestyle-related risk factors 
resulting from social and economic changes. 
Obesity and overweight, arterial 
hypertension, inadequate physical activity, 
hypercholesterolemia and addiction are the 
first leading five risk factors, causing 68% 
of risk factors burden and 11% of total 
burden of diseases, leading to 1.6 million 
disability adjusted life years.5-7 From three 
major groups of diseases and injuries 
(pretransitional, NCDs, and accidents and 
injuries), NCDs cause the most disease 
burden in Iran, 45% for men and 33% for 
women.2,6,7 On the basis of the results 
obtained in the fifth round of survey of NCD 
risk factor surveillance program in Iran in 
2010, among both genders, only 4% in the 
age group of 15-44 years and 1% in the age 
group of 45-64 years had no CHD risk 
factors.3,8 An increase in the median age of 
the population, demographic changes and 
aging, rapid development of urbanization 
and globalization, high prevalence of 
smoking, high prevalence of exposure to 
risk factors for CHD, improper diet, small 
communities and development of 
technologies followed by a decrease in 
physical activity and increase in mental 
tension and stress have resulted in a high 
incidence of this disease.4-7 In addition, 
CHD is the most common cause of death in 
many communities around the world, 
including Iran. Not only CHD does have 
impacts on mortality, but also it affects the 
morbidity, disability and productivity.9-11 In 
Iran, as with other countries, CHD causes 
incidence, mortality and burden of disability 
adjusted life years (DALY) on the 
community.12-17 Several studies on CHD risk 
factors have been conducted in Iran. The 
prevalence has been mentioned only 
sporadically in various reports.18-24 So far, 
the prevalence has not been reported 
collectively for the Iranian provinces. 
Determining prevalence of CHD risk factors 
per province can help us to understand and 
evaluate the epidemiological transition theory 
and changing pattern of diseases in various 
communities in Iran, as well as explaining 
the epidemiology of CHD.17-19 This study 
was aimed to determine the prevalence of 




This secondary, descriptive study 
reports pre-existing data. Prevalence of 
NCD risk factors was defined for the 
provinces of Iran.18 To determine prevalence 
of risk factors for NCD in 2007 and 2009, 
we used reliable reports of NCD risk factors 
surveillance program conducted in Iran, 
such as type II diabetes, hypertension and 
mean body mass index (BMI), smoking, 
hookah smoking and high cholesterol. In the 
study of risk factors for NCDs in Iran, the 
minimum sample size was 2,500 individuals 
in the most sparsely populated province that 
is equivalent to the minimum sample size 
suggested by the World Health Organization 
(WHO) technical recommendations; however, 
the maximum sample size consisted of over 
10020 individuals in Tehran. Sampling from 
the five age groups 15-24, 25-34, 35-44,  
45-54 and 55-64 years, we selected equal 
numbers of men and women to participate in 
this research. Data collection in Iran was 
based on the stepwise approach 
recommended by WHO. Details of the 
method can be seen in other studies.18-24 
 
RESULTS 
Prevalence of hypertension, diabetes, 
smoking and low physical activity in the 15 
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to 64 years old population in Iran in 2007 
and 2009 was reported 17.38%, 9.69%, 
11.39% and 35.21% and 16.09%, 5.56%, 
10.82% and 38.97%, respectively. The 
prevalence was different in the provinces. 
The highest prevalence of hypertension 
(20.85%) was reported for Bushehr province 
followed by East Azarbaijan (20.47%). The 
lowest prevalence of hypertension was 
reported for Yazd and Golestan provinvces 
(12.86% and 12.94%, respectively). 
The highest mean BMI was obtained in 
Mazandaran (26), Gilan (25.9) and 
Khouzestan (25.7) provinces. The lowest 
mean BMI were obtained 22.5 and 22.8 for 
Sistan and Baluchestan and Hormozgan 
provinces, respectively. 
The highest prevalence of diabetes was 
reported from Qom (27.65%) and 
Khouzestan (15.57%), while the lowest was 
reported for Ardabil (4.49%). The highest 
prevalence of high cholesterol was obtained 
in Lorestan province (50.87%) and the 
lowest in Khouzestan province (22.71%). 
East Azarbaijan had the highest prevalence 
of smoking (14.8%) and Kurdistan had the 
lowest (0.16%). Hookah smoking was most 
prevalent in Hormozgan province (7.62%) 
followed by Fars (4.6%), but it was least 
prevalent in Ilam (0.5%) and Kurdistan 
(0.78%). The highest prevalence of physical 
activity was obtained in Sistan and 
Baluchestan (47.84%) province while the 
lowest prevalence was reported for 
Kohgiluyeh and Boyer-Ahmad (22.2%). The 
prevalence of hypertension, diabetes and 
other risk factors for Iran provinces in 2009 
is shown in Table 1. 
 
Table 1: Prevalence of cardiovascular risk factors in Iran – 2009 
 Province HT1 DM2 Cho3 OO4 Smoking hookah PA5 
1 Alborz 16.35 11.12 28.84 48.49 12.82 3.12 35.42
2 Ardabil 17.07 4.49 39.6 48.8 13.2 1.5 38.7
3 West Azarbaijan 17.38 5.49 25.8 48.8 14.5 1.17 38.3
4 East Azarbaijan 20.47 12.82 27.4 47.4 14.8 1.8 36.1
5 Bushehr 20.85 8.65 35.03 40.4 6.3 12.5 46.1
6 Chaharmahal and Bakhtiari 17.18 5.74 32.6 37.79 13.3 1.08 30.04
7 Iilam 14.9 5.16 25.02 39.5 6.6 0.5 26.9
8 Esfahan 15.2 8.33 37.8 44.2 12.3 1.6 38.4
9 Fars 16.91 9.63 40.06 39.76 10.32 4.6 41.52
10 Ghazvin 16.11 10.79 34.27 46.48 11.42 1.16 39.05
11 Gilan 16.79 9.61 35.77 48.56 12.36 1.92 32.4
12 Golestan 12.94 9.61 35.77 46.58 6.98 1.1 38.8
13 Hamadan 15.25 4.09 23.64 41.21 14.03 1.23 33.07
14 Hormozgan 16.6 12.04 37.32 34.8 8.31 7.62 46.28
15 Kerman 14.73 8.96 23.8 34.48 11.21 1.73 40.21
16 Kermnanshah 16.68 7.61 22.73 48.8 10.46 1.25 31.54
17 South Khorasan 15.46 13.57 31.01 30.43 6.7 1.5 29.16
18 Razavi Khorasan 18.67 5.12 31.7 39.61 8.34 4.46 29.48
19 North Khorasan 19.5 10.53 42.8 39.52 7.42 0.87 35.5
20 Khouzestan 17.59 15.57 22.71 46.68 9.39 1.64 40.36
21 Kohgiluyeh and Boyer-Ahmad 14.4 6.78 28.37 43.4 8.74 2.74 22.2
22 Kurdistan 16.63 7.6 29.31 47.09 0.16 0.78 32.99
23 Lorestan 14.81 8.44 50.87 41.75 10.89 2.24 23.68
24 Markazi 14.32 6.95 37.54 42.79 12.57 0.92 29.78
25 Mazandaran 15.47 10.53 42.8 54.35 10.58 1.35 23.26
26 Qom 17.51 27.65 49.87 49.58 10.06 2.47 41.67
27 Semnan 16.03 9.94 49.7 49.99 9.97 9.74 39.97
28 Sistan and Baluchestan 13.36 10.63 33.63 29.91 8.27 10.08 47.84
29 Tehran 16.35 11.12 28.84 48.49 12.82 3.12 35.42
30 Yazd 12.86 11.3 29.58 46.99 7.92 1.44 47.65
31 Zanjan 17.1 5.84 49.4 55.13 11.77 0.63 29.99
1. Hypertension; 2. Type II diabetes; 3. High Cholesterol; 4. Overweight or obese: BMI ≥ 25 kg/m2; 5. Physical 
Activity. 
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DISCUSSION 
In this study, prevalence of CHD risk 
factors has been reported for the Iranian 
provinces. The findings of this study 
indicated that the CHD risk factors in Iran 
are less prevalent than in some of 
neighboring countries. In a similar study 
conducted in Egypt NCD risk factors were 
examined, and prevalence of smoking for 
men, women and the whole population was 
reported as 46%, 0.4% and 24.4%, 
respectively. Prevalence of smoking was 
higher in Egypt than in Iran.  
In addition, the prevalence of diabetes 
and hypertension was 10.5% and 39.7% 
respectively in Egypt. These figures are also 
higher than those of Iran.23 In Kuwait, 
prevalence of type II diabetes, hypertension, 
smoking and high cholesterol were obtained 
11.2%, 10.8%, 23.6% and 38.65% 
respectively.21,23 These figures are higher 
than those of a study conducted in Iran. 
Prevalence of type II diabetes, hypertension, 
smoking and high cholesterol in Qatar, 
according to the national NCD risk factors 
surveillance program, was reported 16.7%, 
32.9%, 16.4% and 32% respectively.23 
According to a study conducted in a heart 
center in Tehran, Iran, 45% of the patients 
with myocardial infarction had a history of 
hypertension, 35% diabetes and 67.6% 
smoking.24 These figures reported for the 
most important factors for myocardial 
infarction were higher than those reported in 
this study. As an explanation for these 
differences, the prevalence of risk factors in 
the referenced study could be affected by the 
number of subjects. The subjects in this 
study were in the age group of 15-64 years 
from all over the country. The referenced 
study examined the major risk factors 
leading to mortality. Another study 
conducted within a 10-year period examined 
the patients with acute myocardial infarction 
in a hospital in northern Iran. Within this 
period, 1236 patients were hospitalized. The 
mean age of patients was 60.6 ± 11.2. 
Among these patients, 62% were men; 
21.6% had history of hypertension, 15.9% 
diabetes, 36% dyslipidemia and 46.3% 
smoking. 18.7% were under 50 years, 40.9% 
50 to 64 years and 40.4% were over 60 
years. In that study, similar to the present 
study, the major determining risk factors for 
CHD were hypertension, diabetes and 
smoking.17 Prevalence of CHD risk factors 
in Iran can then lead to the increase in 
mortality rate. Addressing intervention 
programs to reduce the incidence of risk 




Prevalence of CHD risk factors is the 
main priority for the Iranian health system. 
There is a need for intervention programs in 
the provinces which are at greater risk as 
well as for modification of people’s 
lifestyle. The strength of this study was to 
report the prevalence rates of CHD risk 
factors based on the official provincial 
borders. Therefore, it can help us easily to 
compare and understand this disease 
epidemiologically in order to plan in health 
system. Also, it can be useful for politicians 
and decision makers to introduce and 
understand the problems of CHD. 
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